Coomber B - Search Results

1

Purification and characterization of recombinant human interleukin 4. Biological activities, receptor binding and the generation of monoclonal antibodies.

Solari R, Quint D, Obray H, McNamee A, Bolton E, Hissey P, Champion B, Zanders E, Chaplin A, Coomber B, et al. Solari R, et al. Among authors: coomber b. Biochem J. 1989 Sep 15;262(3):897-908. doi: 10.1042/bj2620897. Biochem J. 1989. PMID: 2590174 Free PMC article.

2

The generation and characterization of antagonist RNA aptamers to human oncostatin M.

Rhodes A, Deakin A, Spaull J, Coomber B, Aitken A, Life P, Rees S. Rhodes A, et al. Among authors: coomber b. J Biol Chem. 2000 Sep 15;275(37):28555-61. doi: 10.1074/jbc.M002981200. J Biol Chem. 2000. PMID: 10882721 Free article.

3

The design of potent, non-peptidic inhibitors of hepatitis C protease.

Andrews DM, Chaignot HM, Coomber BA, Dowle MD, Hind SL, Johnson MR, Jones PS, Mills G, Patikis A, Pateman TJ, Robinson JE, Slater MJ, Trivedi N. Andrews DM, et al. Eur J Med Chem. 2003 Apr;38(4):339-43. doi: 10.1016/s0223-5234(03)00050-3. Eur J Med Chem. 2003. PMID: 12750019

4

Sialidase inhibitors related to zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid-6-propylamides.

Wyatt PG, Coomber BA, Evans DN, Jack TI, Fulton HE, Wonacott AJ, Colman P, Varghese J. Wyatt PG, et al. Among authors: coomber ba. Bioorg Med Chem Lett. 2001 Mar 12;11(5):669-73. doi: 10.1016/s0960-894x(01)00019-1. Bioorg Med Chem Lett. 2001. PMID: 11266166

5

Pyrrolidine-5,5-trans-lactams. 1. Synthesis and incorporation into inhibitors of hepatitis C virus NS3/4A protease.

Andrews DM, Carey SJ, Chaignot H, Coomber BA, Gray NM, Hind SL, Jones PS, Mills G, Robinson JE, Slater MJ. Andrews DM, et al. Org Lett. 2002 Dec 12;4(25):4475-8. doi: 10.1021/ol027013x. Org Lett. 2002. PMID: 12465916

6

Design and synthesis of ethyl pyrrolidine-5,5-trans-lactams as inhibitors of hepatitis C virus NS3/4A protease.

Slater MJ, Andrews DM, Baker G, Bethell SS, Carey S, Chaignot H, Clarke B, Coomber B, Ellis M, Good A, Gray N, Hardy G, Jones P, Mills G, Robinson E. Slater MJ, et al. Among authors: coomber b. Bioorg Med Chem Lett. 2002 Dec 2;12(23):3359-62. doi: 10.1016/s0960-894x(02)00789-8. Bioorg Med Chem Lett. 2002. PMID: 12419361

7

Pyrrolidine-5,5-trans-lactams. 2. The use of X-ray crystal structure data in the optimization of P3 and P4 substituents.

Andrews DM, Chaignot H, Coomber BA, Good AC, Hind SL, Johnson MR, Jones PS, Mills G, Robinson JE, Skarzynski T, Slater MJ, Somers DO. Andrews DM, et al. Org Lett. 2002 Dec 12;4(25):4479-82. doi: 10.1021/ol027014p. Org Lett. 2002. PMID: 12465917

8

Longitudinal Study of Transcriptomic Changes Occurring over Six Weeks of CHOP Treatment in Canine Lymphoma Identifies Prognostic Subtypes.

Mee MW, Faulkner S, Wood GA, Woods JP, Bienzle D, Coomber BL. Mee MW, et al. Among authors: coomber bl. Vet Sci. 2024 Nov 5;11(11):540. doi: 10.3390/vetsci11110540. Vet Sci. 2024. PMID: 39591314 Free PMC article.

9

Characterisation and Sensitivity of a Canine Mast Cell Tumour Line to Oncolytic Viruses.

Mehrani Y, Kakish JE, Napoleoni C, Thompson JJ, Knapp JP, Minott JA, Yates JGE, Stuart D, Coomber BL, Foster RA, Bridle BW, Karimi K. Mehrani Y, et al. Among authors: coomber bl. Vet Comp Oncol. 2024 Nov 11. doi: 10.1111/vco.13024. Online ahead of print. Vet Comp Oncol. 2024. PMID: 39526468

10

Effect of proteasome inhibitors on canine lymphoma cell response to CHOP chemotherapy in vitro.

Prevedel NE, Mee MW, Wood GA, Coomber BL. Prevedel NE, et al. Among authors: coomber bl. Vet Comp Oncol. 2024 Mar;22(1):96-105. doi: 10.1111/vco.12957. Epub 2024 Jan 18. Vet Comp Oncol. 2024. PMID: 38237918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters